Merit Medical Receives FDA Clearance for EmboCube Embolization Gelatin

 

November 29, 2018—Merit Medical Systems, Inc. announced that it has received FDA 510(k) clearance for EmboCube embolization gelatin. EmboCube is indicated for use in embolization of hypervascular tumors.

According to the company, the uniformly cut cubes of gelatin foam have been specifically designed to address preparation concerns and inconsistent particle sizes associated with using traditional gelatin foam sheets as an embolic. EmboCube is preloaded in Merit Medical's Medallion syringe for smooth delivery with minimal to no resistance.

EmboCube embolization gelatin is available in two sizes, 2.5 and 5.0 mm. The 2.5-mm EmboCube is compatible with the company's EmboCath Plus and Merit Maestro microcatheters with a 0.024-inch (0.62-mm) or larger inner diameter. The 5.0-mm EmboCube can be delivered through catheters with a 0.04-inch (1.02-mm) or larger inner diameter. EmboCube is intended for use with Merit Medical's EmboCube delivery kit that includes two injection syringes (1 and 3 mL) and a three-way stopcock for added convenience, stated the company.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.